For example, 21%–47% of patients with anti-GBM disease are anti-neutrophil cytoplasmic antibody (ANCA) positive, with anti-myeloperoxidase (MPO) antibodies being more frequent than anti-proteinase 3 antibodies [7–10]. Here, MPO is linked to glioblastoma.